MedservRegis p.l.c.

MTSE:MDS Stock Report

Market Cap: €70.1m

MedservRegis Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

David O’Connor

Chief executive officer

€526.1k

Total compensation

CEO salary percentage52.47%
CEO tenure5yrs
CEO ownership28.0%
Management average tenure1.4yrs
Board average tenure5yrs

Recent management updates

Analysis Article May 22

We Think Some Shareholders May Hesitate To Increase MedservRegis p.l.c.'s (MTSE:MDS) CEO Compensation

Key Insights MedservRegis' Annual General Meeting to take place on 29th of May Total pay for CEO David O’Connor...

Recent updates

Analysis Article Nov 04

Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 38% Price Jump

MedservRegis p.l.c. ( MTSE:MDS ) shares have had a really impressive month, gaining 38% after a shaky period...
Analysis Article Oct 26

Is MedservRegis (MTSE:MDS) Using Too Much Debt?

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Analysis Article Sep 20

Market Might Still Lack Some Conviction On MedservRegis p.l.c. (MTSE:MDS) Even After 30% Share Price Boost

MedservRegis p.l.c. ( MTSE:MDS ) shareholders would be excited to see that the share price has had a great month...
Analysis Article May 22

We Think Some Shareholders May Hesitate To Increase MedservRegis p.l.c.'s (MTSE:MDS) CEO Compensation

Key Insights MedservRegis' Annual General Meeting to take place on 29th of May Total pay for CEO David O’Connor...
Analysis Article Feb 26

MedservRegis p.l.c. (MTSE:MDS) Stock's 26% Dive Might Signal An Opportunity But It Requires Some Scrutiny

To the annoyance of some shareholders, MedservRegis p.l.c. ( MTSE:MDS ) shares are down a considerable 26% in the last...
Analysis Article Jan 20

Estimating The Fair Value Of MedservRegis p.l.c. (MTSE:MDS)

Key Insights Using the 2 Stage Free Cash Flow to Equity, MedservRegis fair value estimate is €0.43 MedservRegis' €0.50...
Analysis Article Nov 28

Investors Still Aren't Entirely Convinced By MedservRegis p.l.c.'s (MTSE:MDS) Revenues Despite 32% Price Jump

Despite an already strong run, MedservRegis p.l.c. ( MTSE:MDS ) shares have been powering on, with a gain of 32% in the...
Analysis Article Nov 22

Does MedservRegis (MTSE:MDS) Have A Healthy Balance Sheet?

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
Analysis Article Jan 24

MedservRegis p.l.c. (MTSE:MDS) Doing What It Can To Lift Shares

It's not a stretch to say that MedservRegis p.l.c.'s ( MTSE:MDS ) price-to-sales (or "P/S") ratio of 1x right now seems...

CEO Compensation Analysis

How has David O’Connor's remuneration changed compared to MedservRegis's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2025€526k€276k

€5m

Sep 30 2025n/an/a

€5m

Jun 30 2025n/an/a

€5m

Mar 31 2025n/an/a

€3m

Dec 31 2024€442k€296k

€2m

Sep 30 2024n/an/a

€869k

Jun 30 2024n/an/a

-€128k

Mar 31 2024n/an/a

€477k

Dec 31 2023€313k€249k

€1m

Sep 30 2023n/an/a

€2m

Jun 30 2023n/an/a

€3m

Mar 31 2023n/an/a

€2m

Dec 31 2022€281k€199k

€577k

Compensation vs Market: David's total compensation ($USD606.34K) is above average for companies of similar size in the MT market ($USD341.85K).

Compensation vs Earnings: David's compensation has been consistent with company performance over the past year.


CEO

David O’Connor (63 yo)

5yrs
Tenure
€526,060
Compensation

Mr. David Sean O’Connor is Group Chief Executive Officer of Medserv p.l.c. from July 2021 and serves as Executive Chairman from September 2025 and served as its Executive Director until September 2025. Mr....


Leadership Team

NamePositionTenureCompensationOwnership
David O’Connor
CEO & Executive Chairman5yrs€526.06k28%
€ 19.6m
Olivier Bernard
Co-Chief Executive Officer & Executive Director1.4yrs€521.01kno data
Carmelo Bartolo
Co-Chief Executive Officer & Executive Director1.4yrs€534.89kno data
Laragh Cassar
Company Secretaryno data€25.00kno data
Jose Carlos Fernandes
Chief Commercial Officerno datano datano data
Nicola Jaccarini
Company Secretaryno datano datano data
1.4yrs
Average Tenure
55yo
Average Age

Experienced Management: MDS's management team is not considered experienced ( 1.4 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
David O’Connor
CEO & Executive Chairman5yrs€526.06k28%
€ 19.6m
Olivier Bernard
Co-Chief Executive Officer & Executive Director5yrs€521.01kno data
Carmelo Bartolo
Co-Chief Executive Officer & Executive Director5yrs€534.89kno data
Laragh Cassar
Company Secretary5yrs€25.00kno data
Keith Grunow
Non-Executive Independent Director5yrs€35.00kno data
Anthony Diacono
Non-Executive Vice-Chairman5yrs€50.00kno data
Monica Oliveira-Vilabril
Non-Executive Independent Director4.7yrs€25.00kno data
Jean-Pierre Lhote
Non-Executive Independent Director3.9yrs€20.00kno data
5.0yrs
Average Tenure
63yo
Average Age

Experienced Board: MDS's board of directors are considered experienced (5 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/09 06:28
End of Day Share Price 2026/06/03 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MedservRegis p.l.c. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.